A detailed history of Harbour Capital Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Harbour Capital Advisors, LLC holds 10,003 shares of EW stock, worth $654,996. This represents 0.22% of its overall portfolio holdings.

Number of Shares
10,003
Previous 10,318 3.05%
Holding current value
$654,996
Previous $985,000 6.29%
% of portfolio
0.22%
Previous 0.25%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$84.3 - $94.31 $26,554 - $29,707
-315 Reduced 3.05%
10,003 $923,000
Q1 2024

Apr 16, 2024

SELL
$72.54 - $95.56 $5,440 - $7,167
-75 Reduced 0.72%
10,318 $985,000
Q4 2023

Jan 05, 2024

SELL
$61.71 - $77.76 $79,112 - $99,688
-1,282 Reduced 10.98%
10,393 $792,000
Q3 2023

Oct 05, 2023

SELL
$69.28 - $93.38 $432,722 - $583,251
-6,246 Reduced 34.85%
11,675 $808,000
Q2 2023

Jul 10, 2023

SELL
$81.41 - $94.33 $44,938 - $52,070
-552 Reduced 2.99%
17,921 $1.69 Million
Q1 2023

Apr 19, 2023

SELL
$74.26 - $84.51 $711,262 - $809,436
-9,578 Reduced 34.14%
18,473 $1.53 Million
Q4 2022

Jan 13, 2023

SELL
$68.3 - $87.44 $562,450 - $720,068
-8,235 Reduced 22.69%
28,051 $0
Q3 2022

Oct 19, 2022

SELL
$82.37 - $107.29 $6,589 - $8,583
-80 Reduced 0.22%
36,286 $3 Million
Q2 2022

Jul 20, 2022

SELL
$86.5 - $128.27 $3,027 - $4,489
-35 Reduced 0.1%
36,366 $3.46 Million
Q1 2022

Apr 11, 2022

BUY
$101.96 - $128.34 $31,709 - $39,913
311 Added 0.86%
36,401 $4.29 Million
Q4 2021

Jan 12, 2022

BUY
$106.37 - $130.68 $19,146 - $23,522
180 Added 0.5%
36,090 $4.68 Million
Q3 2021

Oct 13, 2021

BUY
$102.91 - $122.75 $68,023 - $81,137
661 Added 1.88%
35,910 $4.07 Million
Q2 2021

Jul 14, 2021

SELL
$83.84 - $104.76 $19,702 - $24,618
-235 Reduced 0.66%
35,249 $3.65 Million
Q1 2021

Apr 12, 2021

BUY
$78.68 - $90.67 $74,352 - $85,683
945 Added 2.74%
35,484 $2.97 Million
Q4 2020

Jan 12, 2021

BUY
$71.69 - $91.23 $52,333 - $66,597
730 Added 2.16%
34,539 $3,000
Q3 2020

Oct 09, 2020

BUY
$67.19 - $87.44 $9,809 - $12,766
146 Added 0.43%
33,809 $2.7 Million
Q2 2020

Jul 21, 2020

BUY
$57.54 - $76.95 $1.29 Million - $1.73 Million
22,439 Added 199.92%
33,663 $2.33 Million
Q1 2020

Apr 08, 2020

BUY
$52.41 - $81.0 $11,163 - $17,253
213 Added 1.93%
11,224 $2.12 Million
Q4 2019

Jan 22, 2020

BUY
$71.7 - $82.09 $7,600 - $8,701
106 Added 0.97%
11,011 $2.57 Million
Q3 2019

Oct 30, 2019

SELL
$61.55 - $75.43 $11,079 - $13,577
-180 Reduced 1.62%
10,905 $2.4 Million
Q2 2019

Jul 10, 2019

BUY
$55.74 - $64.41 $5,462 - $6,312
98 Added 0.89%
11,085 $2.05 Million
Q1 2019

Apr 24, 2019

SELL
$47.89 - $64.05 $29,404 - $39,326
-614 Reduced 5.29%
10,987 $2.1 Million
Q4 2018

Jan 23, 2019

BUY
$46.41 - $56.94 $15,222 - $18,676
328 Added 2.91%
11,601 $1.78 Million
Q3 2018

Nov 07, 2018

SELL
$45.7 - $58.03 $685 - $870
-15 Reduced 0.13%
11,273 $1.96 Million
Q2 2018

Jul 11, 2018

SELL
$42.45 - $51.3 $1,485 - $1,795
-35 Reduced 0.31%
11,288 $1.65 Million
Q1 2018

Apr 18, 2018

BUY
$37.19 - $47.45 $11,752 - $14,994
316 Added 2.87%
11,323 $1.58 Million
Q4 2017

Jan 24, 2018

BUY
$33.79 - $39.39 $53,895 - $62,827
1,595 Added 16.95%
11,007 $1.24 Million
Q3 2017

Nov 08, 2017

BUY
$36.29 - $38.83 $341,561 - $365,467
9,412
9,412 $1.03 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Harbour Capital Advisors, LLC Portfolio

Follow Harbour Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbour Capital Advisors, LLC with notifications on news.